Key result
TNF-alpha contributes to metabolic dysregulation by impairing adipose tissue function and its ability to store excess fuel, inhibiting carbohydrate metabolism and stimulating lipolysis.
This review summarizes the molecular mechanisms by which TNF-alpha impairs adipose tissue function and contributes to obesity-related insulin resistance and dyslipidemia.
TNF-alpha's adipose effects may inform metabolic therapies; hypothesis-generating for cardiometabolic trials.
Dyslipidemia and insulin resistance are commonly associated with catabolic or lipodystrophic conditions (such as cancer and sepsis) and with pathological states of nutritional overload (such as obesity-related type 2 diabetes). Two common features of these metabolic disorders are adipose tissue dysfunction and elevated levels of tumour necrosis factor-alpha (TNF-alpha). Herein, we review the multiple actions of this pro-inflammatory adipokine on adipose tissue biology. These include inhibition of carbohydrate metabolism, lipogenesis, adipogenesis and thermogenesis and stimulation of lipolysis. TNF-alpha can also impact the endocrine functions of adipose tissue. Taken together, TNF-alpha contributes to metabolic dysregulation by impairing both adipose tissue function and its ability to store excess fuel. The molecular mechanisms that underlie these actions are discussed.
No takes yet. Share an insight, caveat, or question.
Cawthorn et al. (2007) conducted a review in Metabolic disorders (dyslipidemia, insulin resistance). TNF-alpha was evaluated. TNF-alpha contributes to metabolic dysregulation by impairing adipose tissue function and its ability to store excess fuel, inhibiting carbohydrate metabolism and stimulating lipolysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: